Healthcare - Biotechnology - NASDAQ - US
$ 4.01
-2.67 %
$ 171 M
Market Cap
-7.86
P/E
Price Target
Average
107.81%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
5.73%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
DiaMedica Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for DMAC of $8.33 , with forecasts ranging from a low of $7 to a high of $10 .
DMAC Lowest Price Target
Wall Street Target
7 USD
74.56%
DMAC Average Price Target
Wall Street Target
8.33 USD
107.81%
DMAC Highest Price Target
Wall Street Target
10 USD
149.38%
REVENUE FORECAST
Revenue Forecast Chart DMAC
EBIT FORECAST
EBIT Forecast Chart DMAC
NET INCOME FORECAST
Net Income Chart DMAC